Skip to main content
SpringerLink
Log in

In Silico Evaluation of Daclizumab and Vitamin D Effects in Multiple Sclerosis Using Agent Based Models

  • Conference paper
  • First Online:
Computational Intelligence Methods for Bioinformatics and Biostatistics (CIBB 2019)

Part of the book series: Lecture Notes in Computer Science ((LNBI,volume 12313))

Abstract

We present an improved version of an agent-based model developed to reproduce the typical oscillating behavior of relapsing remitting multiple sclerosis, a demyelinating autoimmune disease of the central nervous system. The model now includes the effects of vitamin D, a possible immune-modulator that can potentially influence the disease course, as well as the mechanisms of action of daclizumab, a monoclonal antibody that was previously reported as the unique third line treatment for MS, i.e., to be used only in patients who had an inadequate response to the other therapies, but then retired from market due to the arising of severe side effects. The use of this computational approach, capable of qualitatively reproducing the main effects of daclizumab, is used to grasp some useful insights to delineate the possible causes that led to the withdrawal of the drug. Furthermore, we explore the possibility to combine vitamin D administration with a reduced dosage of daclizumab, in order to qualitatively delineate if a combined treatment can lead to similar efficacy, thus entitling a reduced risk of adverse effects.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ascherio, A., et al.: Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study. JAMA 286(24), 3083–3088 (2001)

    Article  Google Scholar 

  2. Barrat, F., et al.: In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J. Exp. Med. 195(5), 603–613 (2002)

    Article  Google Scholar 

  3. Beccuti, M., et al.: GPU accelerated analysis of Treg-Teff cross regulation in relapsing-remitting multiple sclerosis. In: Mencagli, G., et al. (eds.) Euro-Par 2018. LNCS, vol. 11339, pp. 626–637. Springer, Cham (2019). https://doi.org/10.1007/978-3-030-10549-5_49

    Chapter  Google Scholar 

  4. Bhalla, A., Amento, E., Glimcher, B.S.L.: 1,25-Dihydroxyvitamin D3 inhibits antigen-induced T cell activation. J. Immunol. 133(4), 1748–1754 (1984)

    Google Scholar 

  5. Bielekova, B., Becker, B.L.: Monoclonal antibodies in MS: mechanisms of action. Neurology 74(Suppl 1), 31–40 (2010)

    Article  Google Scholar 

  6. Bielekova, B., et al.: Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2R\(\alpha \)-targeted therapy (daclizumab) in multiple sclerosis. Proc. Natl. Acad. Sci. USA 103(15), 5941–5946 (2006)

    Article  Google Scholar 

  7. Bielekova, B., et al.: Intrathecal effects of daclizumab treatment of multiple sclerosis. Neurology 77(21), 1877–1886 (2011)

    Article  Google Scholar 

  8. Chiacchio, F., Pennisi, M., Russo, G., Motta, S., Pappalardo, F.: Agent-based modeling of the immune system: NetLogo, a promising framework. BioMed Res. Int. 2014, 907171 (2014)

    Article  Google Scholar 

  9. Chimeh, M.K., Richmond, P., Heywood, P., Pennisi, M., Pappalardo, F.: Parallelisation strategies for agent based simulation of immune systems. BMC Bioinform. 20(Suppl 6), 1–14 (2019). https://doi.org/10.1186/s12859-019-3181-y

    Article  Google Scholar 

  10. Gold, R., et al.: Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECT): a randomised, double-blind, placebo-controlled trial. Lancet 381, 2167–75 (2013)

    Article  Google Scholar 

  11. Godin, D.: The causal cascade to multiple sclerosis: a model for MS pathogenesis. PLoS One 4(2), e4565 (2009)

    Article  Google Scholar 

  12. Gorman, S., et al.: Topically applied 1,25-Dihydroxyvitamin D3 enhances the suppressive activity of CD4+CD25+ cells in the draining lymph nodes. J. Immunol. 179(9), 6273–6283 (2007)

    Article  Google Scholar 

  13. Gregori, S., Casorati, M., Amuchastegui, S., Smiroldo, S., Davalli, A., Adorini, L.: Regulatory T cells induced by 1 alpha, 25-Dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J. Immunol. 167(4), 1945–1953 (2001)

    Article  Google Scholar 

  14. Lim, J.A., et al.: New feasible treatment for refractory autoimmune encephalitis: low-dose interleukin-2. J. Neuroimmunol. 299, 107–111 (2016)

    Article  Google Scholar 

  15. Luessi, F., Engel, S., Spreer, A., Bittner, S., Zipp, F.: GFAP\(\alpha \) IgG-associated encephalitis upon daclizumab treatment of MS. Neurol. Neuroimmunol. Neuroinflamm. 5(5), e481 (2018)

    Article  Google Scholar 

  16. Martin, R., McFarland, H.F., McFarlin, D.E.: Immunological aspects of demyelinating diseases. Ann. Rev. Immunol. 10, 153–187 (2003)

    Article  Google Scholar 

  17. Pappalardo, F., Pennisi, M., Rajput, A.M., Chiacchio, F., Motta, S.: Relapsing-remitting multiple scleroris and the role of vitamin D : an agent based model. In: ACM-BCB, pp. 744–748 (2014)

    Google Scholar 

  18. Penna, G., et al.: Expression of the inhibitory receptor ILT3 on dendritic cells is dispensable for induction of CD4+Foxp3+ regulatory t cells by 1,25-dihydroxyvitamin D3. Blood 106(10), 3490–3497 (2005)

    Article  Google Scholar 

  19. Pennisi, M., Rajput, A.M., Toldo, L., Pappalardo, F.: Agent based modeling of Treg-Teff cross regulation in relapsing-remitting multiple sclerosis. BMC Bioinf. 14(Suppl 16), S9 (2013)

    Article  Google Scholar 

  20. Pennisi, M., Russo, G., Motta, S., Pappalardo, F.: Agent based modeling of the effects of potential treatments over the blood-brain barrier in multiple sclerosis. J. Immunol. Methods 427, 6–12 (2015)

    Article  Google Scholar 

  21. Ponsonby, A., et al.: Exposure to infant siblings during early life and risk of multiple sclerosis. JAMA 293(4), 463–469 (2005)

    Article  Google Scholar 

  22. Sospedra, M., Martin, R.: Immunology of multiple sclerosis. Annu. Rev. Immunol. 23, 683–747 (2005)

    Article  Google Scholar 

  23. Sundström, P., et al.: An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study. Neurology 62, 2277–2282 (2004)

    Article  Google Scholar 

  24. Vélez de Mendizábal, N., et al.: Modeling the effector - regulatory T cell cross-regulation reveals the intrinsic character of relapses in multiple sclerosis. BMC Syst. Biol. 5(1), 1–15 (2011)

    Article  Google Scholar 

  25. Wilensky, U.: NetLogo, Center for connected learning and computer-based modeling, Northwestern University, Evanston, IL (1999). http://ccl.northwestern.edu/netlogo/

  26. Wuest, S.C., et al.: A role for interleukin-2 transpresentation in dendritic cellmediated T cell activation in humans, as revealed by daclizumab therapy. Nat. Med. 17(5), 604–609 (2011)

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Computer Science Institute, DiSIT, University of Eastern Piedmont, Alessandria, Italy

    Marzio Pennisi

  2. Department of Mathematics and Computer Science, University of Catania, Catania, Italy

    Giuseppe Sgroi & Giuseppe Alessandro Parasiliti Palumbo

  3. Department of Drug Science, University of Catania, Catania, Italy

    Giulia Russo & Francesco Pappalardo

Authors
  1. Marzio Pennisi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Giulia Russo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Giuseppe Sgroi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Giuseppe Alessandro Parasiliti Palumbo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Francesco Pappalardo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marzio Pennisi .

Editor information

Editors and Affiliations

  1. University of Bergamo, Bergamo, Italy

    Paolo Cazzaniga

  2. University of Milano-Bicocca, Milan, Italy

    Daniela Besozzi

  3. National Research Council, Segrate, Italy

    Ivan Merelli

  4. Università degli Studi di Trieste, Trieste, Italy

    Luca Manzoni

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this paper

Check for updates. Verify currency and authenticity via CrossMark

Cite this paper

Pennisi, M., Russo, G., Sgroi, G., Palumbo, G.A.P., Pappalardo, F. (2020). In Silico Evaluation of Daclizumab and Vitamin D Effects in Multiple Sclerosis Using Agent Based Models. In: Cazzaniga, P., Besozzi, D., Merelli, I., Manzoni, L. (eds) Computational Intelligence Methods for Bioinformatics and Biostatistics. CIBB 2019. Lecture Notes in Computer Science(), vol 12313. Springer, Cham. https://doi.org/10.1007/978-3-030-63061-4_25

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-63061-4_25

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-63060-7

  • Online ISBN: 978-3-030-63061-4

  • eBook Packages: Computer ScienceComputer Science (R0)

Publish with us

Policies and ethics

Search

Navigation